₹10,000 करोड़ क्या है?
ऐतिहासिक पृष्ठभूमि
मुख्य प्रावधान
10 points- 1.
आवंटन का उद्देश्य बायोफार्मा शक्ति योजना का समर्थन करना है।
- 2.
धन का उपयोग बायोफार्मास्युटिकल क्षेत्र में अनुसंधान और विकास को बढ़ावा देने के लिए किया जाएगा।
- 3.
आवंटन बायोफार्मा नवाचार के लिए एक अनुकूल वातावरण बनाने में मदद करेगा।
- 4.
धन विभिन्न तंत्रों के माध्यम से वितरित किया जाएगा, जैसे कि अनुदान और सब्सिडी।
- 5.
आवंटन भारत में बायोफार्मास्युटिकल उद्योग के विकास में योगदान देगा।
- 6.
आवंटन नई दवाओं और उपचारों के विकास का समर्थन करेगा।
- 7.
आवंटन भारत को बायोफार्मास्युटिकल अनुसंधान और विनिर्माण के लिए एक वैश्विक केंद्र बनाने में मदद करेगा।
- 8.
आवंटन संसदीय अनुमोदन के अधीन होगा।
- 9.
आवंटन की निगरानी यह सुनिश्चित करने के लिए की जाएगी कि इसका प्रभावी ढंग से उपयोग किया जाए।
- 10.
आवंटन स्वास्थ्य सेवा क्षेत्र के प्रति सरकार की प्रतिबद्धता को दर्शाता है।
हालिया विकास
5 विकासThe allocation is a significant increase compared to previous years.
The allocation reflects the government's focus on the healthcare sector.
The allocation is expected to boost the biopharmaceutical industry in India.
The allocation is part of the government's broader strategy to promote innovation and research and development.
The allocation is subject to parliamentary scrutiny.
सामान्य प्रश्न
61. What is the ₹10,000 crore allocation, and why is it important for UPSC GS Paper 3?
The ₹10,000 crore allocation refers to a specific sum of money earmarked in the government's budget for a particular purpose. In this case, it's the proposed allocation for the Biopharma SHAKTI scheme. It is important for UPSC GS Paper 3 because it relates to economic development, government budgeting, government schemes, and healthcare policy.
परीक्षा युक्ति
Remember that budgetary allocations reflect the government's priorities. For the exam, focus on the scheme it supports (Biopharma SHAKTI) and its potential impact on the biopharmaceutical industry.
2. What are the key provisions associated with this ₹10,000 crore allocation?
As per the concept data, the key provisions are: * The allocation is intended to support the Biopharma SHAKTI scheme. * The funds will be used to promote research and development in the biopharmaceutical sector. * The allocation will help in creating a conducive environment for biopharma innovation. * The funds will be disbursed through various mechanisms, such as grants and subsidies. * The allocation will contribute to the growth of the biopharmaceutical industry in India.
- •The allocation is intended to support the Biopharma SHAKTI scheme.
- •The funds will be used to promote research and development in the biopharmaceutical sector.
- •The allocation will help in creating a conducive environment for biopharma innovation.
- •The funds will be disbursed through various mechanisms, such as grants and subsidies.
- •The allocation will contribute to the growth of the biopharmaceutical industry in India.
परीक्षा युक्ति
Focus on the purpose of the allocation and the sectors it aims to benefit. Understanding the disbursement mechanisms (grants, subsidies) is also crucial.
3. How does the ₹10,000 crore allocation for Biopharma SHAKTI scheme work in practice?
In practice, the ₹10,000 crore allocation will be channeled through various government agencies and institutions to support research and development projects, infrastructure development, and skill development programs in the biopharmaceutical sector. Grants and subsidies will be provided to eligible companies and research institutions. The aim is to stimulate innovation, attract investment, and boost the growth of the biopharmaceutical industry in India.
4. What is the legal framework governing the ₹10,000 crore allocation?
The allocation is part of the Union Budget, which is presented to Parliament under Article 112 of the Constitution.
परीक्षा युक्ति
Remember the constitutional basis: Article 112 (Union Budget).
5. What are the potential challenges in the implementation of the Biopharma SHAKTI scheme with this ₹10,000 crore allocation?
Potential challenges include: * Ensuring efficient and transparent disbursement of funds. * Monitoring the utilization of funds to prevent misuse. * Attracting high-quality research proposals. * Addressing regulatory hurdles in the biopharmaceutical sector. * Coordinating efforts among various government agencies and research institutions.
- •Ensuring efficient and transparent disbursement of funds.
- •Monitoring the utilization of funds to prevent misuse.
- •Attracting high-quality research proposals.
- •Addressing regulatory hurdles in the biopharmaceutical sector.
- •Coordinating efforts among various government agencies and research institutions.
6. How significant is the ₹10,000 crore allocation for the Biopharma SHAKTI scheme in boosting the biopharmaceutical industry in India?
The ₹10,000 crore allocation is a significant step towards boosting the biopharmaceutical industry in India. It demonstrates the government's commitment to promoting research and development, fostering innovation, and creating a conducive environment for growth. This allocation can attract investment, generate employment, and improve healthcare outcomes in the country.